Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Cash from Financing Activities: 2021-2024

Historic Cash from Financing Activities for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to $14.8 million.

  • Biofrontera's Cash from Financing Activities fell 39.68% to $4.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $14.8 million, marking a year-over-year decrease of 73.40%. This contributed to the annual value of $14.8 million for FY2024, which is 76.38% up from last year.
  • Per Biofrontera's latest filing, its Cash from Financing Activities stood at $14.8 million for FY2024, which was up 76.38% from $8.4 million recorded in FY2023.
  • Biofrontera's Cash from Financing Activities' 5-year high stood at $43.2 million during FY2021, with a 5-year trough of $8.4 million in FY2023.
  • In the last 3 years, Biofrontera's Cash from Financing Activities had a median value of $14.0 million in 2022 and averaged $12.4 million.
  • Per our database at Business Quant, Biofrontera's Cash from Financing Activities tumbled by 67.54% in 2022 and then soared by 76.38% in 2024.
  • Yearly analysis of 4 years shows Biofrontera's Cash from Financing Activities stood at $43.2 million in 2021, then plummeted by 67.54% to $14.0 million in 2022, then slumped by 40.01% to $8.4 million in 2023, then soared by 76.38% to $14.8 million in 2024.